Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.
De Leersnyder
H
H
Bresson
J L
JL
de Blois
M-C
MC
Souberbielle
J-C
JC
Mogenet
A
A
Delhotal-Landes
B
B
Salefranque
F
F
Munnich
A
A
D000015:Abnormalities, Multiple / Q000097:blood / Q000188:drug therapy* / Q000235:genetics*; D000070:Acebutolol / Q000008:administration & dosage / Q000627:therapeutic use; D000293:Adolescent; D058671:Adrenergic beta-1 Receptor Antagonists; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D021081:Chronobiology Disorders / Q000097:blood / Q000188:drug therapy*; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D015331:Cohort Studies; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008550:Melatonin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D018342:Receptors, Adrenergic, beta-1 / Q000502:physiology; D012890:Sleep / Q000187:drug effects* / Q000502:physiology*; D013577:Syndrome
D058671:Adrenergic beta-1 Receptor Antagonists; D000319:Adrenergic beta-Antagonists; D018342:Receptors, Adrenergic, beta-1; D000070:Acebutolol; D008550:Melatonin